Activists To Seek $660 Million For Breast Cancer Research, Legislation To Declare An “Epidemic”
In Brief: Adamson is Acting Frederick Director; Fischinger Heads Hollings Center; ASCO Has New Exec. Dir.
NIH Authorization Bills Require NCI To Spend 10% On Cancer control
NCAB Urges $2 Tax On Cigarettes To Reduce Smoking
NIH Not Proactive, Healy Tells NCAB ‘Beset’ By Issues
Pryor Calls For Price Regulation Of Drugs In Health Reform
Trending Stories
- U.S. News rankings for cancer hospitals shift again with inclusion of Medicare Advantage data
Rankings now include a list of Best Regional Hospitals for Equitable Access - Robert Gallo named founding director of Microbial Oncology Program at TGH Cancer Institute
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Proposed rule by CMS would expand access to cancer treatment at tribal facilities
- A view from the BMT unit on the day a Russian cruise missile hit Kyiv’s Ohmatdyt hospital
- Platinum drugs are off the shortage list, but the underlying problem is unsolved
FDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.”